---
name: J3.1 Long-Term Follow-up After Treatment for Histologic or Cytologic HSIL 

externalData:
- resources

data:
- 
  resourceType: Patient
  name: Joanne Smith
  gender: female
  birthDate: 1991-01-01
  extension:
  -
    url: http://hl7.org/fhir/us/core/StructureDefinition/us-core-birthsex
    valueCode: F
-
  resourceType: DiagnosticReport
  code: LOINC#65753-6 Cervix Pathology biopsy report
  status: final
  conclusionCode:
  - SNOMEDCT#285838002 Cervical intraepithelial neoplasia grade 2 (disorder)
  effectiveDateTime: 2019-10-01
- 
  resourceType: Procedure
  code: SNOMED#236876003 Wedge biopsy of cervix (procedure)
  performedDateTime: 2019-12-01
  status: completed
- 
  resourceType: DiagnosticReport
  code: LOINC#21440-3 Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by Probe
  status: final
  conclusionCode:
  - SNOMEDCT#787724008 Human papillomavirus deoxyribonucleic acid test negative (finding)
  effectiveDateTime: 2020-06-01


results:
  Recommendation: 
    short: 'Surveillance'
    date: '2021-06-02'
    group: 'Management Surveillance (J.3.1)'
    details:
    - 'Primary HPV testing or cotesting is recommended at 6, 18, and 30 months following treatment.'
    - 'After 3 consecutive negative tests have been obtained, surveillance can continue at 3-year intervals for at least 25 years, even if this is past age 65, and may continue for as long as the patient remains in good health.'
  WhichRarityMadeTheRecommendation: 4